Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay
about
Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligandsAltered immune response in mice deficient for the G protein-coupled receptor GPR34International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsN-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathwaysReceptors for acylethanolamides-GPR55 and GPR119Endocannabinoids as Guardians of MetastasisSurfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI InhibitorsTools for GPCR drug discovery.The cannabinoid acids, analogs and endogenous counterpartsReduced food intake and body weight in mice deficient for the G protein-coupled receptor GPR82LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptorOxidized lipids and lysophosphatidylcholine induce the chemotaxis, up-regulate the expression of CCR9 and CXCR4 and abrogate the release of IL-6 in human monocytesThe ligand specificity of the G-protein-coupled receptor GPR34Phytocannabinoids beyond the Cannabis plant - do they exist?International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertilitySignaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of Rac activity.Anatomical transcriptome of G protein-coupled receptors leads to the identification of a novel therapeutic candidate GPR52 for psychiatric disorders.GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment.Novel Therapeutic GPCRs for Psychiatric Disorders.International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsIdentification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Purification of family B G protein-coupled receptors using nanodiscs: Application to human glucagon-like peptide-1 receptorPharmacological characterization of GPR55, a putative cannabinoid receptorIdentification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.Novel signaling mechanisms in the ovary during oocyte maturation and ovulation.Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.GPR55 ligands promote receptor coupling to multiple signalling pathways.Neuronal nitric oxide synthase-dependent elevation in adiponectin in the rostral ventrolateral medulla underlies g protein-coupled receptor 18-mediated hypotension in conscious rats.Aiming drug discovery at lysophosphatidic acid targets.N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal hornDistribution of endogenous farnesyl pyrophosphate and four species of lysophosphatidic acid in rodent brain.Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.Genome-wide sequencing for the identification of rearrangements associated with Tourette syndrome and obsessive-compulsive disorderScreening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.GPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaquesRegulation of circulating endocannabinoids associated with cancer and metastases in mice and humans.Regulation of Constitutive GPR3 Signaling and Surface Localization by GRK2 and β-arrestin-2 Overexpression in HEK293 Cells.
P2860
Q24311776-E741C456-F9B8-4941-8C6D-02BE829DF5B8Q24594464-32D13183-9569-4E9B-A3C2-817C39B35586Q24605072-F0146088-6342-4C63-A3A5-515477091D1DQ24634334-E369EAAD-E4B4-4439-BBE0-EF94BDA82108Q24647538-1A7F2C84-364B-40A2-BF2E-888EF06906C6Q26766163-F2861816-4564-4C62-84CE-788F0AEA1397Q26823990-C6FCEF72-F4FC-43BA-BEA2-683598F481C4Q27007472-00BFBD65-A0FF-416D-8A04-25CCDA04E877Q27009735-128460BC-9091-4751-8828-E9324D2D560CQ27310678-CC510CB4-0443-40FA-B904-FEDA6B0589D8Q27310850-D929A2DD-34EB-4AFF-909F-9596C2E9B6B3Q28248592-7E1EE909-DAC5-4765-9F5F-6C4658E3B827Q28260358-91B825D1-D2D5-4EAD-8655-EBE9F4E6D390Q28286497-F85FD4E6-DFAF-4E74-AFE1-DA4B24DA629CQ28298445-A89C07E0-9FED-4394-BD1B-D005E9ECB55CQ28303095-D43B6D84-4B04-4CB6-8417-FB42D735ECBBQ28304843-AAF10BFF-80DE-4DCC-8FF9-AED3F000D19AQ28506753-70F065E6-08EF-4B92-B0FD-500CAF22255DQ28511668-A4A4D77C-664F-4524-B22D-9BBFDB6A5A8DQ30407406-AD67EFAF-7C67-457C-8F20-9520D8D51201Q30429523-E9F4201A-5E12-432F-9610-0211027A072AQ30486707-7DA3F719-A0FC-455C-819E-6DE9465325DDQ30990011-543E349E-B643-4B4E-938B-B0F2C95E17E9Q33636763-6AEA2E02-EA5E-4E2D-90EA-C607FB298844Q33793135-98413718-307D-4F1F-9B1F-C5FB12588E43Q33869340-5FE92813-7909-46F5-AB64-0E9F7FAF69C6Q33887246-CB5CC393-1FB3-45F9-B838-54338B1B0693Q33924835-29ED7702-6B58-4B69-830A-A3849B2D4D37Q34025116-420B7B62-E04C-4778-9675-4248550AD000Q34098246-88E18FD5-86BC-437C-8677-290FAB6B21FDQ34186264-2F8124BB-9488-4D50-B718-00A4BB6CCAC9Q34339759-E9717C1B-EAA7-4605-A2EA-85CECDCAB3EDQ34356128-6FC76355-C743-4FC5-BA43-CCFDE2918E9EQ34378141-B9EDDFA8-7320-455F-983C-EA76A5BA935DQ34453695-D7954200-CF14-40BE-8A7F-D6A06C4D928EQ34517994-AA1E3600-DD32-437D-A68F-CEE317582037Q34581803-BD1A20A4-5CF5-415B-B12D-792EFBE45936Q34682812-84AAE159-2567-467D-A8BB-9D08E6DC1624Q34781231-BFCB072C-9084-44B1-9639-F02418E2A065Q34795621-D0755660-C1D4-4794-996B-837257A58E15
P2860
Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Lipid G protein-coupled recept ...... beta-arrestin PathHunter assay
@ast
Lipid G protein-coupled recept ...... beta-arrestin PathHunter assay
@en
Lipid G protein-coupled recept ...... beta-arrestin PathHunter assay
@nl
type
label
Lipid G protein-coupled recept ...... beta-arrestin PathHunter assay
@ast
Lipid G protein-coupled recept ...... beta-arrestin PathHunter assay
@en
Lipid G protein-coupled recept ...... beta-arrestin PathHunter assay
@nl
prefLabel
Lipid G protein-coupled recept ...... beta-arrestin PathHunter assay
@ast
Lipid G protein-coupled recept ...... beta-arrestin PathHunter assay
@en
Lipid G protein-coupled recept ...... beta-arrestin PathHunter assay
@nl
P2093
P2860
P3181
P356
P1476
Lipid G protein-coupled recept ...... beta-arrestin PathHunter assay
@en
P2093
Deborah G Nguyen
Fabiola Shelton
Francella Otero
Jeremy S Caldwell
Yu Alice Chen
P2860
P304
P3181
P356
10.1074/JBC.M806516200
P407
P577
2009-05-01T00:00:00Z